FIELD: medicine.
SUBSTANCE: method involves determining hemoglobin level in peripheral blood, erythrocytes deformability index, vegetative Kerdo index and non-enzymatic fibrinolysis duration. Hemoglobin level is multiplied by 0.809, erythrocytes deformability index is multiplied by 3.247 and the two products are summed. Vegetative Kerdo index value is multiplied by 0.804, non-enzymatic fibrinolysis duration is multiplied by 0.365 and the products are summed. The second sum is subtracted from the first one and 20.89 is added to the difference. General organism fatigue quantitative estimate is obtained in this way. General organism fatigue value being less than 5 points, organism working capacity is evaluated as satisfactory. The value being from 5 inclusive to 37, moderate fatigue degree is considered to be the case. The value being from 37 inclusive to 69, medium severity fatigue is considered to be the case; from 69 inclusive to 100, fatigue level is considered to be above the medium level. The value being equal to or greater than 100 points, expressed general organism fatigue is considered to be the case.
EFFECT: high accuracy of estimate.
7 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMPLEX QUANTITATIVE EVALUATION OF GENERAL BODY FATIGUE | 2006 |
|
RU2315549C1 |
METHOD OF QUANTATIVE EVALUATION OF INTEGRATION OF FUNCTIONAL SYSTEMS OF ORGANISM BY VALUE OF COEFFICIENT OF FUNCTIONAL INVOLVEMENT | 2008 |
|
RU2357657C1 |
METHOD FOR QUANTITATIVE EVALUATION OF GENERAL BODY FATIGUE ACCORDING TO THE STATE OF THE SUPREME NEURAL ACTIVITY | 2006 |
|
RU2315548C1 |
QUANTITATIVE METHOD FOR ESTIMATING GENERAL ORGANISM FATIGUE LEVEL FROM ANALYZER SYSTEM STATE | 2006 |
|
RU2308875C1 |
METHOD OF CRITICAL ADAPTABILITY APPRAISAL IN ADOLESCENTS | 2010 |
|
RU2426127C1 |
METHOD FOR DETERMINING A RISK OF DEVELOPING A CEREBROVASCULAR PATHOLOGY IN MYELOPROLIFERATIVE DISEASES | 2020 |
|
RU2727005C1 |
METHOD OF IMPROVING FITNESS TO PHYSICAL ACTIVITY OF SPORTSMAN | 2004 |
|
RU2284805C2 |
METHOD FOR REHABILITATION TREATMENT OF ONCOGYNAECOLOGIC PATIENTS OF REPRODUCTIVE AGE SUFFERING UTERINE CORPUS AND CERVICAL CANCER AND RECEIVED ANTICANCER THERAPY | 2014 |
|
RU2548506C1 |
METHOD FOR PREVENTION OF MYOPIA PROGRESSION | 2010 |
|
RU2444338C1 |
METHOD OF EARLY DETERMINATION OF ABNORMAL REFRACTOGENESIS IN CHILDREN | 2014 |
|
RU2567273C1 |
Authors
Dates
2007-12-27—Published
2006-08-07—Filed